Seattle-based Shape Therapeutics raises $112M to develop RNA-editing and gene therapies
Shape CEO Francois Vigneault. (Shape photo) Shape Therapeutics, a Seattle preclinical biotech company developing RNA editing and gene therapy technologies, has raised $ 112 million. The company’s RNA editing technologies …